CHANTA POU: Open Payments
NPI 1023350485 · WOONSOCKET, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 34 payments from 9 companies in 2025. Trend: 2023 $541 · 2024 $645 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $272 |
| E.R. Squibb & Sons, L.L.C. | 2 | $105 |
| Vanda Pharmaceuticals Inc. | 4 | $83 |
| Janssen Pharmaceuticals, Inc | 3 | $63 |
| Neurocrine BioSciences, Inc. | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: VRAYLAR, COBENFY, FANAPT, SPRAVATO, INGREZZA, REXULTI, TRINTELLIX, Auvelity.
Industry payments across RI — which companies pay providers there.
